Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sonic Healthcare Limited

SAB
Current price
16.46 EUR +0.054 EUR (+0.33%)
Last closed 16.19 EUR
ISIN AU000000SHL7
Sector Healthcare
Industry Diagnostics & Research
Exchange Stuttgart Exchange
Capitalization 7 913 010 116 EUR
Yield for 12 month -13.51 %
1Y
3Y
5Y
10Y
15Y
SAB
21.11.2021 - 28.11.2021

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia. Address: Grosvenor Place, Sydney, NSW, Australia, 2000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

25.0031

Dividend Yield

3.96 %

Current Year

+8 167 648 416 EUR

Last Year

+9 338 668 091 EUR

Current Quarter

Last Quarter

Current Year

+6 888 157 001 EUR

Last Year

+7 734 464 342 EUR

Current Quarter

Last Quarter

Key Figures SAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 626 703 217 EUR
Operating Margin TTM 10.39 %
PE Ratio 25.0031
Return On Assets TTM 3.82 %
PEG Ratio
Return On Equity TTM 6.8 %
Wall Street Target Price
Revenue TTM 8 965 977 935 EUR
Book Value 16.49 EUR
Revenue Per Share TTM
Dividend Share 1.06 EUR
Quarterly Revenue Growth YOY 14.1 %
Dividend Yield 3.96 %
Gross Profit TTM 2 841 963 805 EUR
Earnings per share 0.65 EUR
Diluted Eps TTM 0.65 EUR
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY 0.6 %
Profit Margin 5.7 %

Dividend Analytics SAB

Dividend growth over 5 years

28 %

Continuous growth

7 years

Payout Ratio 5 years average

58 %

Dividend History SAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.64
Ex Dividend Date 04.09.2024
Forward Annual Dividend Yield 3.96 %
Last Split Factor
Payout Ratio 97.95 %
Last Split Date
Dividend Date

Stock Valuation SAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 25.0031
Forward PE 25.1889
Enterprise Value Revenue 1.8791
Price Sales TTM 0.8826
Enterprise Value EBITDA 10.1554
Price Book MRQ 1.6173

Financials SAB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SAB

For 52 weeks

13.57 EUR 18.51 EUR
50 Day MA 16.29 EUR
Shares Short Prior Month
200 Day MA 17.05 EUR
Short Ratio
Shares Short
Short Percent